Physician

Jamie Langenhan Abbott, MD

According to 2025 Medicare claims, Jamie Abbott, MD (NPI: 1578958716) practices dermatology in the Fayetteville-Springdale-Rogers, AR market, with the plurality of this provider's patient population coming from Washington, AR. This provider's primary affiliated billing organization is OZARK DERMATOLOGY CLINIC (NPI: 1134207483; TIN: 710836130) and primary practice location at 72703-4984.

Abbott's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 884 traditional Medicare patients, billed 8,629 HCPCS/CPT codes, and received $601,438 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,160 prescription claims across 447 beneficiaries totaling $311,067 in drug costs, led by Taltz Autoinjector (Ixekizumab). Open Payments data shows 34 records totaling $624. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $33,241 to $601,438. Similarly, Part D prescription costs have risen steadily, from $3,205 to $311,067. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$301K$601K2019 Medicare payment: $33,241 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $136,273 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $152,290 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $255,682 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $560,704 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $601,438 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019220836$33,241
20207423,905$136,273
20217253,803$152,290
20227644,863$255,682
20237457,424$560,704
20248848,629$601,438

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$156K$311K2015 Drug cost: $3,205 (USD; Tot_Drug_Cst)2016 Drug cost: $4,894 (USD; Tot_Drug_Cst)2017 Drug cost: $20,341 (USD; Tot_Drug_Cst)2018 Drug cost: $16,218 (USD; Tot_Drug_Cst)2019 Drug cost: $34,791 (USD; Tot_Drug_Cst)2020 Drug cost: $150,653 (USD; Tot_Drug_Cst)2021 Drug cost: $244,992 (USD; Tot_Drug_Cst)2022 Drug cost: $253,078 (USD; Tot_Drug_Cst)2023 Drug cost: $110,956 (USD; Tot_Drug_Cst)2024 Drug cost: $311,067 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151849$3,205
20162963$4,894
201790219$20,341
201865136$16,218
2019124221$34,791
2020286643$150,653
2021301738$244,992
2022321753$253,078
2023385944$110,956
20244471,160$311,067

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more298407$76
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more531729$56
11102Biopsy of related skin growth, first growth292348$52
17000Destruction of precancer skin growth, 1 growth336424$29
17003Destruction of precancer skin growth, 2-14 growths2691,650$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Taltz AutoinjectorIxekizumab19532$147,581
Clobetasol PropionateClobetasol Propionate1464,103$9,795
MetronidazoleMetronidazole341,025$2,333
Triamcinolone AcetonideTriamcinolone Acetonide1755,503$1,902
FluorouracilFluorouracil23666$1,607

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.34$624ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jamie Langenhan Abbott, MD?

Tedicare shows public-source Medicare data for Jamie Langenhan Abbott, MD (NPI 1578958716), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jamie Langenhan Abbott, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jamie Langenhan Abbott, MD?

Jamie Langenhan Abbott, MD is linked to OZARK DERMATOLOGY CLINIC (billing NPI 1134207483) in the available physician profile data.

Does Jamie Langenhan Abbott, MD have Open Payments data?

Jamie Langenhan Abbott, MD has 34 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.